Order Article Reprints

Heo Y-J, Lee N, Choi S-E, Jeon J-Y, Han S-J, Kim D-J, Kang Y, Lee K-W, Kim H-J. Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway. Biomedicines. 2022; 10(5):1032. https://doi.org/10.3390/biomedicines10051032

Heo, Yu-Jung, Nami Lee, Sung-E Choi, Ja-Young Jeon, Seung-Jin Han, Dae-Jung Kim, Yup Kang, Kwan-Woo Lee, and Hae-Jin Kim. 2022. "Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway" Biomedicines 10, no. 5: 1032. https://doi.org/10.3390/biomedicines10051032

Heo, Y. -J., Lee, N., Choi, S. -E., Jeon, J. -Y., Han, S. -J., Kim, D. -J., Kang, Y., Lee, K. -W., & Kim, H. -J. (2022). Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway. Biomedicines, 10(5), 1032. https://doi.org/10.3390/biomedicines10051032